Thus, assessment of HER2/neu levels by non-invasive MR imaging will provide a tremendous tool for cancer diagnosis/prognosis, design of treatment strategies, and monitoring the effectiveness of the treatment. This evidence concerns the gene ERBB2 and cancer.